nanoMR Scores $13M

Albuquerque-based nanoMR, a firm developing diagnostics tools for detecting pathogens in whole blood, has raised $13M in a funding round. The firm said the Series B round was led by Excel Venture Management, and also included Healthcare Ventures, vSpring Capital, The Dow Chemical Company, and Sun Mountain Capital. The firm said that Excel's Dr. Steven Gullans, and Healthcare Ventures Gus Lawlor have both joined the board as part of the funding. The firm intends to use the funding for further development, clinical studies, and preparation for product launch. More information »